MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells

被引:276
作者
Formosa, A. [1 ,2 ]
Markert, E. K. [3 ]
Lena, A. M. [1 ]
Italiano, D. [1 ]
Finazzi-Agro, E. [1 ]
Levine, A. J. [3 ]
Bernardini, S. [1 ]
Garabadgiu, A. V. [4 ]
Melino, G. [1 ,2 ]
Candi, E. [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy
[2] IDI IRCCS, Rome, Italy
[3] Simons Ctr Syst Biol, Inst Adv Study, Princeton, NJ USA
[4] St Petersburg Technol Inst, Mol Pharmacol Lab, St Petersburg, Russia
关键词
microRNAs; prostate cancer; metastasis; MESENCHYMAL TRANSITION; EXPRESSION; CLUSTER; TUMOR; STEMNESS; TARGETS; MIRNAS; P53;
D O I
10.1038/onc.2013.451
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
miRNAs act as oncogenes or tumor suppressors in a wide variety of human cancers, including prostate cancer (PCa). We found a severe and consistent downregulation of miRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 region in metastatic cell lines as compared with normal prostatic epithelial cells (PrEC). In specimens of human prostate (28 normals, 99 primary tumors and 13 metastases), lower miRNA levels correlated significantly with a higher incidence of metastatic events and higher prostate specific antigen (PSA) levels, with similar trends observed for lymph node invasion and the Gleason score. We transiently transfected 10 members of the 14q32.31 cluster in normal prostatic epithelial cell lines and characterized their affect on malignant cell behaviors, including proliferation, apoptosis, migration and invasion. Finally, we identified FZD4, a gene important for epithelial-to-mesenchymal transition in (PCa), as a target of miR-377.
引用
收藏
页码:5173 / 5182
页数:10
相关论文
共 51 条
[1]   miRNAs, 'stemness' and skin [J].
Aberdam, Daniel ;
Candi, Eleonora ;
Knight, Richard A. ;
Melino, Gerry .
TRENDS IN BIOCHEMICAL SCIENCES, 2008, 33 (12) :583-591
[2]   MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival [J].
Afanasyeva, E. A. ;
Mestdagh, P. ;
Kumps, C. ;
Vandesompele, J. ;
Ehemann, V. ;
Theissen, J. ;
Fischer, M. ;
Zapatka, M. ;
Brors, B. ;
Savelyeva, L. ;
Sagulenko, V. ;
Speleman, F. ;
Schwab, M. ;
Westermann, F. .
CELL DEATH AND DIFFERENTIATION, 2011, 18 (06) :974-984
[3]   14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a [J].
Agueli, Cecilia ;
Cammarata, Giuseppe ;
Salemi, Domenico ;
Dagnino, Lea ;
Nicoletti, Roberta ;
La Rosa, Maria ;
Messana, Francesca ;
Marfia, Anna ;
Bica, Maria Grazia ;
Coniglio, Maria Luisa ;
Pagano, Maria ;
Fabbiano, Francesco ;
Santoro, Alessandra .
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (08) :575-578
[4]   miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration [J].
Amelio, Ivano ;
Lena, Anna Maria ;
Viticchie, Giuditta ;
Shalom-Feuerstein, Ruby ;
Terrinoni, Alessandro ;
Dinsdale, David ;
Russo, Giandomenico ;
Fortunato, Claudia ;
Bonanno, Elena ;
Spagnoli, Luigi Giusto ;
Aberdam, Daniel ;
Knight, Richard Austen ;
Candi, Eleonora ;
Melino, Gerry .
JOURNAL OF CELL BIOLOGY, 2012, 199 (02) :347-363
[5]   MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets [J].
Antonov, A. V. ;
Knight, R. A. ;
Melino, G. ;
Barlev, N. A. ;
Tsvetkov, P. O. .
CELL DEATH AND DIFFERENTIATION, 2013, 20 (02) :367-367
[6]   miR-15a and miR-16-1 in cancer: discovery, function and future perspectives [J].
Aqeilan, R. I. ;
Calin, G. A. ;
Croce, C. M. .
CELL DEATH AND DIFFERENTIATION, 2010, 17 (02) :215-220
[7]   The microRNA and p53 families join forces against cancer [J].
Barlev, N. A. ;
Sayan, B. S. ;
Candi, E. ;
Okorokov, A. L. .
CELL DEATH AND DIFFERENTIATION, 2010, 17 (02) :373-375
[8]  
Bartkowiak D, 1999, CYTOMETRY, V37, P191, DOI 10.1002/(SICI)1097-0320(19991101)37:3<191::AID-CYTO5>3.0.CO
[9]  
2-U
[10]   MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma [J].
Boll, K. ;
Reiche, K. ;
Kasack, K. ;
Moerbt, N. ;
Kretzschmar, A. K. ;
Tomm, J. M. ;
Verhaegh, G. ;
Schalken, J. ;
von Bergen, M. ;
Horn, F. ;
Hackermueller, J. .
ONCOGENE, 2013, 32 (03) :277-285